The Team
A Proven Execution from Bench to Market
James Chen, M.D.
Founder & CSO
Developing PD-1 Into Community
Now advancing CMB — an oral PD-1 amplifier designed to improve efficacy and enable community deployment without adding toxicity.
-
End-to-End Commercialization: Led Antican® from invention to market with regulatory approvals in 3 countries and patents across 32+ nations.
- Academic Contribution: Publisher of "Small Animal Oncology" — the first professional oncology reference book in Chinese.
- Strategic Insights: Author of an ongoing analytical series on PD-1 market dynamics and community oncology strategies.
Yoshihiro Shimizu, DVM
Global Commercializer
Strategic Market Access
- Big Pharma Veteran: Decades of executive experience, including as General Manager for Elanco Japan (former Eli Lilly group).
- Market Navigator: Deep expertise in global product launches and commercial strategy.